Company Of The Day: Roche Holdings

-4.00%
Downside
20.35
Market
19.54
Trefis
NWSA: News logo
NWSA
News

What?

Roche Holdings (OTCMKTS: RHHBY) Q3 2022 revenue declined 6% to CHF 14.74 billion ($14.8 billion).

Why?

Relevant Articles
  1. Amazon Stock To Edge Past The Consensus In Q4
  2. What To Expect From McDonald’s Stock Post Q4?
  3. Here’s What To Expect From Johnson Controls’ Q1
  4. How Will Bristol Myers Squibb Stock Trend Post Q4 Results?
  5. Exxon Mobil Stock Likely To Trade Lower Post Q4
  6. Here’s What To Expect From Electronic Arts’ Q3

A decline in demand for Covid-19 diagnostics and treatments outweighed the gains that the company made with its hemophilia and multiple sclerosis drugs.

So What?

Roche stock was down by almost 1.5% in early trading on Tuesday although it recovered later in the day.

See Our Complete Analysis For Roche

What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.

 Returns Oct 2022
MTD [1]
2022
YTD [1]
2017-22
Total [2]
 RHHBY Return 1% -20% 44%
 S&P 500 Return 4% -22% 66%
 Trefis Multi-Strategy Portfolio 3% -24% 201%

[1] Month-to-date and year-to-date as of 10/19/2022
[2] Cumulative total returns since the end of 2016

 

Invest with Trefis Market-Beating Portfolios
See all Trefis Price Estimates